0001209191-17-050892.txt : 20170831 0001209191-17-050892.hdr.sgml : 20170831 20170831161618 ACCESSION NUMBER: 0001209191-17-050892 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170830 FILED AS OF DATE: 20170831 DATE AS OF CHANGE: 20170831 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Leschly Nick CENTRAL INDEX KEY: 0001578408 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35966 FILM NUMBER: 171063563 MAIL ADDRESS: STREET 1: C/O BLUEBIRD BIO, INC. STREET 2: 840 MEMORIAL DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: bluebird bio, Inc. CENTRAL INDEX KEY: 0001293971 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 60 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 339-499-9300 MAIL ADDRESS: STREET 1: 60 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: Genetix Pharmaceuticals Inc DATE OF NAME CHANGE: 20040616 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-08-30 0 0001293971 bluebird bio, Inc. BLUE 0001578408 Leschly Nick C/O BLUEBIRD BIO, INC. 60 BINNEY STREET CAMBRIDGE MA 02142 1 1 0 0 President and CEO Common Stock 2017-06-29 5 G 0 E 10000 0.00 D 339368 D Common Stock 2017-08-30 4 S 0 25667 115.1793 D 313701 D Common Stock 17186 I Nick Leschly 2001 Trust The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 22, 2016. The range of prices for the transaction reported on this line was $115.00 to $115.75. The average weighted price was $115.1793. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. /s/ Jason F. Cole, Attorney-in-Fact 2017-08-31